Patient Condition
The patient developed weakness in both lower limbs since the age of 54, and was diagnosed with ALS (limb onset) at the age of 55. At the time of diagnosis, ALSFRS-R was 31, FVC was 70%, and the progression rate was moderate (monthly drop of 0.9 points). Choose comprehensive supportive treatment + Ziluzole.
Treatment Timeline
| Phase | Details | Date |
|---|
| Comprehensive treatment initiated | | |
| sustainable integrated management | | |
| long-term management | | |
Treatment Outcome
| before | ALSFRS-R 31, monthly drop 0.9, FVC 70%, weakness of both lower limbs |
|---|
| after | ALSFRS-R 26 points, 30-month decline of 5 points (81% delay), FVC 64% |
|---|
| highlight | Comprehensive supportive treatment delayed progress by 81% after 30 months, making it cost-effective |
|---|